pharmaphorum1d
Novartis taps Microsoft’s AI expertise for drug development
Joint research activities will be carried out at Novartis’ sites in Basel, Switzerland, and Dublin, Ireland, as well as at the Microsoft Research Lab in Cambridge, UK.
mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032 Featuring Pfizer, Moderna, and Novartis with 650 Patents Combined
The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer therapeutics market was valued at USD 13.23 ...
Seizures Pipeline Insight Analysis Report, Competitive Analysis of Eisai, Novartis, Johnson & Johnson, and Neurelis
The "Seizures Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The Seizures treatment pipeline analysis provides an overview of recent advancements ...